Journal
NEUROCHEMICAL RESEARCH
Volume 29, Issue 9, Pages 1687-1693Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1023/B:NERE.0000035803.64724.17
Keywords
dihydro-beta-erythroidine; dopamine; in vivo microdialysis; mecamylamine; nicotine; somatodendritic; dopamine release; ventral tegmental area
Categories
Ask authors/readers for more resources
We examined the effects of nicotine perfusion into the ventral tegmental area (VTA) on extracellular dopamine (DA) levels in rats using in vivo microdialysis. Local perfusion with nicotine for 80 min (10-100 muM) modestly increased (similar to105-131% of basal) the extracellular DA levels in the VTA of rats that had been pretreated with saline for 5 days. In animals that had been pretreated with nicotine for 5 days (0.3 mg/kg, s.c.), perfusion with nicotine for 80 min (10-100 muM) dose-dependently increased the extracellular DA levels in the VTA of rats and did so to a greater extent than in saline-pretreated animals (125-171% of basal). Co-perfusion through the dialysis probe with 100 muM mecamylamine, a nonselective nicotinic acetylcholine receptor ( nAChR) antagonist, or 100 muM dihydro-beta-erythroidine, a high affinity and competitive nAChR antagonist, attenuated the enhancement of extracellular DA levels produced by 100 muM nicotine alone. These results suggest that local nicotine challenge potentiated the somatodendritic DA release after nicotine preexposure by stimulation of high-affinity nAChRs in the VTA.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available